Atacicept in Multiple Glomerular Diseases

Clinical trial NCT06983028 · RECRUITING

Trial details

NCT number: NCT06983028
Sponsor: Vera Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

pMN IgAN Nephrotic Syndrome MCD FSGS

Start date: 2025-07-07
Primary completion: 2027-11-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.